Several studies have reported on COX-2 expression and disease recurrence in invasive breast cancer and have shown elevated levels of COX-2 expression to be associated with a more aggressive cancer and decreased survival (Ristimaki et al, 2002; Haffty et al, 2008). This evidence concerns the gene PTGS2 and cancer.